<DOC>
	<DOCNO>NCT01811199</DOCNO>
	<brief_summary>Hypothesis : Dexamethasone reduces postoperative emesis thyroidectomy mastectomy patient .</brief_summary>
	<brief_title>Dexamethasone Reduces Postoperative Emesis Decreasing PGF2α LTC4 Levels</brief_title>
	<detailed_description>This study do study effectiveness dexamethasone prevention postoperative emesis breast thyroid surgery time , mechanism action investigate . In prospective , randomize control trial hypothesize corticosteroid exert antiemetic effect postoperative period via plasma prostaglandin F2 alpha ( PGF2 α ) plasma leukotriene C4 ( LTC4 ) inhibition .</detailed_description>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>breast thyroid cancer patient neoadjuvant treat NSAID steroid usage heallthy volunteer , sign informed consent one sign consent form NSAID steroid user</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Thyroid cancer</keyword>
	<keyword>Breast cancer</keyword>
	<keyword>Dexamethasone</keyword>
	<keyword>Emesis</keyword>
</DOC>